| Literature DB >> 31635411 |
Xiya Zhang1, Haibo Hu2.
Abstract
Fine particulate matter, known as PM2.5, is closely related to a range of adverse health outcomes and ultimately imposes a high economic cost on the society. While we know that the costs associated with PM2.5-related health outcomes are not uniform geographically, a few researchers have considered the geographical variations in these costs because of a lack of high-resolution data for PM2.5 and population density. Satellite remote sensing provides highly precise, high-resolution data about how PM2.5 and population density vary spatially, which can be used to support detailed health-related assessments. In this study, we used high-resolution PM2.5 concentration and population density based on remote sensing data to assess the effects of PM2.5 on human health and the related economic costs in the Beijing-Tianjin-Hebei (BTH) region in 2016 using exposure-response functions and the relationship between health and economic costs. The results showed that the PM2.5-related economic costs were unevenly distributed and as with the population density, the costs were mainly concentrated in urban areas. In 2016, the economic costs of PM2.5-related health endpoints amounted to 4.47% of the total gross domestic product in the BTH region. Of the health endpoints, the cost incurred by premature deaths accounted for more than 80% of the total economic costs associated with PM2.5. The results of this study provide new and detailed information that could be used to support the implementation of national and regional policies to reduce air pollution.Entities:
Keywords: Fine particulate matter; economic cost; health impact; spatial assessment
Mesh:
Substances:
Year: 2019 PMID: 31635411 PMCID: PMC6843963 DOI: 10.3390/ijerph16203994
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Study area and locations of PM2.5 monitoring stations.
Figure 2(a) Census data, (b) DMSP/OLS NTL, and (c) land use data of the study area in 2010.
PM2.5 exposure-response coefficients for the chosen health endpoints.
| Health Impact | Exposure-Response Coefficients 95% CI | Reference |
|---|---|---|
| All-cause mortality | 0.0040 (0.0019, 0.0062) | [ |
| Respiratory hospital admission | 0.0109 (0, 0.0221) | [ |
| Cardiovascular hospital admission | 0.0068 (0.0043, 0.0093) | [ |
| Outpatient visits to pediatrics | 0.0056 (0.0020, 0.09) | [ |
| Outpatient visits to internal medicine | 0.0049 (0.0027, 0.07) | [ |
| Acute bronchitis | 0.0790 (0.027, 0.13) | [ |
| Chronic bronchitis | 0.01009 (0.00366, 0.01559) | [ |
| Asthma attack | 0.02100 (0.0145, 0.03) | [ |
Mortality and morbidity at the health endpoints used in the analysis (95% CI).
| Health Impact | EBeijing | ETianjin | EHebei | Reference |
|---|---|---|---|---|
| All-cause mortality | 5.20‰ | 5.54‰ | 6.36‰ | [ |
| Respiratory hospital admission | 2.03% | 1.47% | 2.11% | [ |
| Cardiovascular hospital admission | 1.57% | 1.14% | 1.64% | [ |
| Outpatient visits to pediatrics | 77.00‰ | 52.58‰ | 96.10‰ | [ |
| Outpatient visits to internal medicine | 22.20% | 31.70% | 21.80% | [ |
| Acute bronchitis | 3.80% | 3.80% | 3.80% | [ |
| Chronic bronchitis | 0.69% | 3.80% | 3.80% | [ |
| Asthma attack | 0.94% | 0.94% | 0.94% | [ |
Economic costs per case of different health effects (USD).
| Health Impact | ECBeijing | ECTianjin | ECHebei | Method | References |
|---|---|---|---|---|---|
| All-cause mortality | 775,333.85 | 502,461.50 | 383,481.63 | VOSL | [ |
| Respiratory hospital admission | 1096.17 | 1096.17 | 1096.17 | COI | [ |
| Cardiovascular hospital admission | 2595.54 | 2595.54 | 2595.54 | COI | [ |
| Outpatient visits to pediatrics | 69.28 | 45.06 | 32.35 | COI | [ |
| Outpatient visits to internal medicine | 69.28 | 45.06 | 32.35 | COI | [ |
| Acute bronchitis | 376.39 | 304.86 | 211.21 | COI | [ |
| Chronic bronchitis | 42,643.36 | 27,635.38 | 21,091.49 | VOSL | [ |
| Asthma attack | 277.06 | 224.41 | 155.39 | COI | [ |
Figure 3Spatial distributions of the (a) annual mean PM2.5 concentration, (b) cold season mean PM2.5 concentration, and (c) warm season mean PM2.5 concentration.
Figure 4The population density across the BTH region in 2016.
Estimates of the cases (and 95% CI) attributable to PM2.5 pollution (C0 = 35 μg/m3) (Unit: Thousand cases).
| Health Impact | Beijing | Tianjin | Hebei |
|---|---|---|---|
| All-cause mortality | 15.934 (7.871, 23.718) | 11.004 (5.413, 16.447) | 62.067 (30.566, 92.676) |
| Respiratory hospital admission | 149.415 (0, 250.340) | 70.832 (0, 120.835) | 500.378 (0, 849.737) |
| Cardiovascular hospital admission | 77.810 (51.511, 101.725) | 36.617 (24.128, 48.089) | 259.152 (170.962, 339.954) |
| Outpatient visits to pediatrics | 320.725 (122.453, 484.648) | 142.390 (53.991, 216.506) | 1277.715 (485.322, 1939.757) |
| Outpatient visits to internal medicine | 819.571 (470.404, 1126.711) | 759.872 (434.312, 1048.723) | 2,566.449 (1468.419, 3538.570) |
| Acute bronchitis | 784.711 (529.764, 819.832) | 553.107 (356.541, 586.417) | 2659.836 (1735.294, 2808.604) |
| Chronic bronchitis | 48.028 (19.580, 67.412) | 31.481 (12.684, 44.600) | 154.244 (62.332, 218.013) |
| Asthma attack | 112.297 (86.531, 138.935) | 74.929 (57.147, 93.883) | 365.481 (279.469, 456.461) |
Figure 5Spatial distribution of the health impacts associated with PM2.5 in (a) 2016, and during the (b) cold season and (c) warm season of 2016 (unit cases).
Average total economic cost (billion USD) as a proportion of the BTH’s average GDP.
| Health Impact | Economic Cost (95%CI) | ||
|---|---|---|---|
| Beijing | Tianjin | Heibei | |
| All-cause mortality | 12.35 (6.10, 18.39) | 5.53 (2.72, 8.26) | 23.80 (11.72, 35.54) |
| Respiratory hospital admission | 0.16 (0, 0.27) | 0.08 (0, 0.13) | 0.55 (0, 0.93) |
| Cardiovascular hospital admission | 0.20 (0.13, 0.26) | 0.10 (0.06, 0.12) | 0.67 (0.44, 0.88) |
| Outpatient visits to pediatrics | 0.02 (0.01, 0.03) | 0.01 (0.002, 0.01) | 0.04 (0.02, 0.06) |
| Outpatient visits to internal medicine | 0.06 (0.03, 0.08) | 0.03 (0.02, 0.05) | 0.08 (0.05, 0.11) |
| Acute bronchitis | 0.30 (0.20, 0.31) | 0.17 (0.11, 0.18) | 0.56 (0.37, 0.59) |
| Chronic bronchitis | 2.04 (0.83, 2.87) | 0.86 (0.35, 1.23) | 3.25 (1.31, 4.60) |
| Asthma attack | 0.03 (0.02, 0.04) | 0.02 (0.01, 0.02) | 0.05 (0.04, 0.07) |
| Total loss | 15.16 (7.34, 22.26) | 6.80 (3.28, 10.01) | 29.00 (13.95, 42.79) |
| GDP | 386.45 | 269.26 | 482.81 |
| Total loss/GDP | 3.90% | 2.52% | 6.00% |
Figure 6Spatial distribution of the total economic costs associated with PM2.5 in (a) 2016, and in (b) the cold season and (c) the warm season in 2016.